Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

ELIXA Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)631-638.e7
JournalAmerican Heart Journal
Volume169
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

Cite this